Non-Pharmacological Option for Self-Administered Nausea Relief in the Pediatric ED:Essential Oil Blend Aromatic Inhaler

2.50
Hdl Handle:
http://hdl.handle.net/10755/623677
Category:
Full-text
Format:
Text-based Document
Type:
Poster
Level of Evidence:
N/A
Research Approach:
N/A
Title:
Non-Pharmacological Option for Self-Administered Nausea Relief in the Pediatric ED:Essential Oil Blend Aromatic Inhaler
Author(s):
McBryde, Sonya; Langley, Denise; Hartenstein, Melinda
Lead Author STTI Affiliation:
Non-member
Author Details:
Sonya McBryde, BSN, RN, CPEN, CEN; Denise Langley, MBA, BSN, RN; Melinda Hartenstein, BSN, RN, CEN, CPEN
Abstract:

Poster presentation

Session F presented Friday, September 15, 2017

Purpose: Our staff wanted to offer a non-pharmacological option for nausea that is self-administered/controlled, nurse directed without continued nursing supervision, and has no limit /maximum use/frequency. Although QueaseEASE (QE) is widely used in labor/delivery, adult PACU, and adult/pediatric HemOnc areas; QueaseEASE has little previous use in pediatric or adult emergency departments.

Design: The staff developed project compared standard pharmacological nausea relief usage before and after patients' self directed use of QueaseEASE. Cost analysis and patient satisfaction were trended.

Setting:
The study occurred in the public academic health center/research university level one trauma center pediatric emergency department.

Participants/Subjects: Inclusion criteria: Any patient 2yrs and older that has not received Zofran within 30 minutes of presentation complaining of nausea. Exclusion criteria: Any mechanical or obstructive pathophysiology (appendicitis, bowel obstruction, intussusception etc.).

Methods:After obtaining verbal consent from the patient/family, QE is demonstrated by the staff member. QE is left with the patient /family to self-administer. Patients, families or staff may halt the trial at any time. If no resolution of nausea occurs within 30 minutes, other measures are offered. Staff (RN) and patient/family (PT) complete a survey after the trial is completed/stopped. Utilization review of standard treatments were noted before and after the study.

Results/Outcomes: 40 cases total: males 38%, females 62%; Shifts: days 45%, evenings 40%, nights 15%;
Ages: 17mo (per mom’s request)-1, 2-4yo-10%, 5-7yo-10%, 8-10yo-18%, 11-13yo-13%, 14-16yo-28%, 17-19yo-20%. Chief complaints: Neuro: syncope, HA, TBI, CHI; Cardiac/Resp: asthma, CP, CF, pneumonia, pneumothorax; GI/GU: abd pain, kidney stones, DM, constipation, IUP, menses, ovarian cyst, UC, C diff complications; ENT: eye pain, sore throat; Musculoskeletal/skin: fractures, abscess; Other: HemOnc port concerns, drug/alcohol ingestions, anxiety, suicide gestures/ideation, depression.

Results of surveys (RN=nurse response, PT=patient/family response): Nausea reduced/eliminated 74% RN , 79% PT; Family satisfied 76% RN; Trial stopped at family request 10% (due to smell); Trial stopped due to nursing judgement 14% (60% patient not like the smell, 40% patient started vomiting); Additional interventions required 37% (Of which 75% patients still satisfied with QE, Of which 64% patients would still request QE first); Zofran/IVF 36%, Ativan 14%, Narcotic or pain med14%, IVF alone 28%, other antiemetic 7%; Patient would request QE again 79%PT (NOTE: not all survey questions were answered by all patients-percentages are from the answers given -so spreads are not always100%).

Implications: Due to our small daily census (30-50) and exclusion criteria, the sample size is small (40) and over a 2-3month period. Girls were enrolled twice as often as boys. Teens were enrolled twice as often as school age. One 17mo was included per mom’s request due to her concurrent use of home essential oils during the triage. In spite of our small sample size, we had a broad representation of pediatric emergency department chief complaints. Overall patients and families were very satisfied with QueaseEASE (76%) and would request it again (79%). A year after QueaseEASE was approved for use in the pediatric emergency department, QueaseEASE is still frequently offered to school age and older patients with nausea and stress/anxiety related issues.

Keywords:
Pediatric; Nausea; Emergency Department
Repository Posting Date:
5-Dec-2017
Date of Publication:
5-Dec-2017
Conference Date:
2017
Conference Name:
Emergency Nursing 2017
Conference Host:
Emergency Nurses Association
Conference Location:
St. Louis, Missouri, USA
Description:
ENA 2017: Education, Networking, Advocacy. Held at America's Center Convention Center, St. Louis, Missouri

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePosteren
dc.evidence.levelN/Aen
dc.research.approachN/Aen
dc.titleNon-Pharmacological Option for Self-Administered Nausea Relief in the Pediatric ED:Essential Oil Blend Aromatic Inhaleren_US
dc.contributor.authorMcBryde, Sonyaen
dc.contributor.authorLangley, Deniseen
dc.contributor.authorHartenstein, Melindaen
dc.contributor.departmentNon-memberen
dc.author.detailsSonya McBryde, BSN, RN, CPEN, CEN; Denise Langley, MBA, BSN, RN; Melinda Hartenstein, BSN, RN, CEN, CPENen
dc.identifier.urihttp://hdl.handle.net/10755/623677-
dc.description.abstract<p>Poster presentation</p> <p>Session F presented Friday, September 15, 2017</p> <p>Purpose: Our staff wanted to offer a non-pharmacological option for nausea that is self-administered/controlled, nurse directed without continued nursing supervision, and has no limit /maximum use/frequency. Although QueaseEASE (QE) is widely used in labor/delivery, adult PACU, and adult/pediatric HemOnc areas; QueaseEASE has little previous use in pediatric or adult emergency departments.</p> <p>Design: The staff developed project compared standard pharmacological nausea relief usage before and after patients' self directed use of QueaseEASE. Cost analysis and patient satisfaction were trended.</p> <p>Setting: <br />The study occurred in the public academic health center/research university level one trauma center pediatric emergency department.</p> <p>Participants/Subjects: Inclusion criteria: Any patient 2yrs and older that has not received Zofran within 30 minutes of presentation complaining of nausea. Exclusion criteria: Any mechanical or obstructive pathophysiology (appendicitis, bowel obstruction, intussusception etc.).</p> <p>Methods:After obtaining verbal consent from the patient/family, QE is demonstrated by the staff member. QE is left with the patient /family to self-administer. Patients, families or staff may halt the trial at any time. If no resolution of nausea occurs within 30 minutes, other measures are offered. Staff (RN) and patient/family (PT) complete a survey after the trial is completed/stopped. Utilization review of standard treatments were noted before and after the study.</p> <p>Results/Outcomes: 40 cases total: males 38%, females 62%; Shifts: days 45%, evenings 40%, nights 15%; <br />Ages: 17mo (per mom&rsquo;s request)-1, 2-4yo-10%, 5-7yo-10%, 8-10yo-18%, 11-13yo-13%, 14-16yo-28%, 17-19yo-20%. Chief complaints: Neuro: syncope, HA, TBI, CHI; Cardiac/Resp: asthma, CP, CF, pneumonia, pneumothorax; GI/GU: abd pain, kidney stones, DM, constipation, IUP, menses, ovarian cyst, UC, C diff complications; ENT: eye pain, sore throat; Musculoskeletal/skin: fractures, abscess; Other: HemOnc port concerns, drug/alcohol ingestions, anxiety, suicide gestures/ideation, depression.</p> <p>Results of surveys (RN=nurse response, PT=patient/family response): Nausea reduced/eliminated 74% RN , 79% PT; Family satisfied 76% RN; Trial stopped at family request 10% (due to smell); Trial stopped due to nursing judgement 14% (60% patient not like the smell, 40% patient started vomiting); Additional interventions required 37% (Of which 75% patients still satisfied with QE, Of which 64% patients would still request QE first); Zofran/IVF 36%, Ativan 14%, Narcotic or pain med14%, IVF alone 28%, other antiemetic 7%; Patient would request QE again 79%PT (NOTE: not all survey questions were answered by all patients-percentages are from the answers given -so spreads are not always100%).</p> <p>Implications: Due to our small daily census (30-50) and exclusion criteria, the sample size is small (40) and over a 2-3month period. Girls were enrolled twice as often as boys. Teens were enrolled twice as often as school age. One 17mo was included per mom&rsquo;s request due to her concurrent use of home essential oils during the triage. In spite of our small sample size, we had a broad representation of pediatric emergency department chief complaints. Overall patients and families were very satisfied with QueaseEASE (76%) and would request it again (79%). A year after QueaseEASE was approved for use in the pediatric emergency department, QueaseEASE is still frequently offered to school age and older patients with nausea and stress/anxiety related issues.</p>en
dc.subjectPediatricen
dc.subjectNauseaen
dc.subjectEmergency Departmenten
dc.date.available2017-12-05T15:53:39Z-
dc.date.issued2017-12-05-
dc.date.accessioned2017-12-05T15:53:39Z-
dc.conference.date2017en
dc.conference.nameEmergency Nursing 2017en
dc.conference.hostEmergency Nurses Associationen
dc.conference.locationSt. Louis, Missouri, USAen
dc.descriptionENA 2017: Education, Networking, Advocacy. Held at America's Center Convention Center, St. Louis, Missourien
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.